{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:52:37Z","timestamp":1761843157531},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":7042,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1097\/01.lab.0000090221.95883.41","type":"journal-article","created":{"date-parts":[[2003,10,16]],"date-time":"2003-10-16T20:04:18Z","timestamp":1066334658000},"page":"1489-1495","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Xeroderma Pigmentosum Group A Protein and Chemotherapy Resistance in Human Germ Cell Tumors"],"prefix":"10.1016","volume":"83","author":[{"given":"Friedemann","family":"Honecker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Stoop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Wolter","family":"Oosterhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leendert H J","family":"Looijenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/01.LAB.0000090221.95883.41_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ijc.2910590108","article-title":"Testicular cancer in nine northern European countries","volume":"59","author":"Adami","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib2","series-title":"The metabolic and molecular basis of inherited disease","first-page":"677","article-title":"Nucleotide excision repair syndromes: xeroderma pigmentosum, cockayne syndrome, and trichothiodystrophy","author":"Bootsma","year":"2001"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer","volume":"94","author":"Bosken","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3835(95)03696-T","article-title":"DNA repair enzyme expression in chronic lymphocytic leukemia vis-a-vis nitrogen mustard drug resistance","volume":"90","author":"Bramson","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib5","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1073\/pnas.96.11.6090","article-title":"Recognition of nonhybridizing base pairs during nucleotide excision repair of DNA","volume":"96","author":"Buschta-Hedayat","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib6","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1073\/pnas.162369899","article-title":"Somatic stem cells and the kinetics of mutagenesis and carcinogenesis","volume":"99","author":"Cairns","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/88.19.1346","article-title":"DNA repair: Enzymatic mechanisms and relevance to drug response","volume":"88","author":"Chaney","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI117388","article-title":"Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy","volume":"94","author":"Dabholkar","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib9","first-page":"6058","article-title":"Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts","volume":"48","author":"Dijt","year":"1988","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib10","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.072067999","article-title":"Curing metastatic testicular cancer","volume":"99","author":"Einhorn","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib11","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.2001.19.10.2647","article-title":"Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy\u2013results from an international study group","volume":"19","author":"Fizazi","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002800100363","article-title":"In vitro studies on the mechanisms of oxaliplatin resistance","volume":"48","author":"Hector","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bjc.1987.25","article-title":"Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents","volume":"55","author":"Ijiri","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","article-title":"Mechanisms of resistance to cisplatin","volume":"478","author":"Kartalou","year":"2001","journal-title":"Mutat Res"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2002.20.6.1551","article-title":"Role of P53 and MDM2 in treatment response of human germ cell tumors","volume":"20","author":"Kersemaekers","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0960-9822(99)80118-3","article-title":"Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours","volume":"9","author":"Koberle","year":"1999","journal-title":"Curr Biol"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1530\/ror.0.0040090","article-title":"Pathogenesis of testicular germ cell tumours","volume":"4","author":"Looijenga","year":"1999","journal-title":"Rev Reprod"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib18","first-page":"263","article-title":"Pathobiology of testicular germ cell tumors: Views and news","volume":"24","author":"Looijenga","year":"2002","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm0796-804","article-title":"A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation","volume":"2","author":"Lutzker","year":"1996","journal-title":"Nat Med"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib20","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/sj.onc.1204394","article-title":"A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells","volume":"20","author":"Lutzker","year":"2001","journal-title":"Oncogene"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib21","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1074\/jbc.270.8.4152","article-title":"DNA repair protein XPA binds replication protein A (RPA)","volume":"270","author":"Matsuda","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/annonc\/mdg242","article-title":"Towards an understanding of the biological basis of the response to cisplatin-based chemotherapy in germ-cell tumors","volume":"14","author":"Mayer","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/carcin\/23.6.1039","article-title":"Low amounts of the DNA repair XPA protein are sufficient to recover UV-resistance","volume":"23","author":"Muotri","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/1097-0142(19830201)51:3<408::AID-CNCR2820510309>3.0.CO;2-4","volume":"51","author":"Oosterhuis","year":"1983","journal-title":"Cancer"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib25","first-page":"181","article-title":"Host-cell reactivation of cis-diamminedichloroplatinum(II)-treated SV40 DNA in normal human, Fanconi anaemia and xeroderma pigmentosum fibroblasts","volume":"132","author":"Poll","year":"1984","journal-title":"Mutat Res"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/269518a0","article-title":"Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation","volume":"269","author":"Potten","year":"1977","journal-title":"Nature"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib27","first-page":"4260","article-title":"Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors","volume":"58","author":"Rao","year":"1998","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib29","first-page":"764","article-title":"A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin","volume":"61","author":"Rosenberg","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib30","first-page":"656","article-title":"3-Methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance","volume":"62","author":"Roth","year":"2002","journal-title":"Cancer Res"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/labinvest.3780302","article-title":"Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: Diagnostic and etiological implications","volume":"81","author":"Stoop","year":"2001","journal-title":"Lab Invest"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00001813-200206000-00010","article-title":"DNA repair protein levels vis-a-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program","volume":"13","author":"Xu","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1097\/01.LAB.0000090221.95883.41_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0968-0004(00)89095-7","article-title":"Cisplatin and DNA repair in cancer chemotherapy","volume":"20","author":"Zamble","year":"1995","journal-title":"Trends Biochem Sci"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722034717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722034717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T13:23:32Z","timestamp":1675949012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722034717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0023683722034717"],"URL":"https:\/\/doi.org\/10.1097\/01.lab.0000090221.95883.41","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xeroderma Pigmentosum Group A Protein and Chemotherapy Resistance in Human Germ Cell Tumors","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/01.LAB.0000090221.95883.41","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}